1. Genetic tests
  2. Lynch syndrome - MLH1 promoter hypermethylation and BRAF V600E mutation

Lynch syndrome - MLH1 promoter hypermethylation and BRAF V600E mutation

Genetic test Export to PDF
Full name:
Lynch syndrome - MLH1 promoter hypermethylation and BRAF V600E mutation
Description:

MLH1 promoter gene hypermethylation and screening for V600E BRAF mutation
Test type:
Clinical
Test specialty:
Molecular Genetics
Test purpose:
Carrier diagnosis,
Therapeutic Management
Specimen:
Paraffine block of tumor
Method category:
Targeted variant analysis
Methylation analysis
Method technique:
MLPA based techniques
Laboratory:
Centre de Génétique Humaine - CHU Sart-Tilman
RIZIV code:
565515-565526
EQA:
  • 2015 Lynch Syndrome EMQN
  • 2021 Lynch Syndrome EMQN
Accreditation (ISO 15189):
2022-02-24 / 2026-02-23
Turnaround time (maximum):
2 months
Document(s):
Created:
24 Dec 2019 - 07:59
Changed:
23 Jan 2023 - 13:12
URL:
https://www.chu.ulg.ac.be/jcms/c_14484761/fr/etude-du-gene-mlh1-sur-tumeur